Source:http://linkedlifedata.com/resource/pubmed/id/17103011
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2006-11-19
|
| pubmed:abstractText |
Hyper-IgD and periodic fever syndrome (HIDS) is a hereditary autoinflammatory syndrome, characterized by recurrent inflammatory attacks. Treatment of HIDS is difficult. Recently, the IL-1ra analogue anakinra was reported to be successful in aborting the IgD inflammatory attacks in a vaccination model. We report a clinical case of spectacular reduction of febrile attacks in a severe HIDS patient.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
1573-2665
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
29
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
763
|
| pubmed:dateRevised |
2007-3-21
|
| pubmed:meshHeading |
pubmed-meshheading:17103011-Fever,
pubmed-meshheading:17103011-Humans,
pubmed-meshheading:17103011-Hypergammaglobulinemia,
pubmed-meshheading:17103011-Immunoglobulin D,
pubmed-meshheading:17103011-Inflammation,
pubmed-meshheading:17103011-Interleukin 1 Receptor Antagonist Protein,
pubmed-meshheading:17103011-Syndrome
|
| pubmed:year |
2006
|
| pubmed:articleTitle |
Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis.
|
| pubmed:affiliation |
AP-HM Timone-Enfants, F-13385, Marseilles Cedex 05, France.
|
| pubmed:publicationType |
Journal Article,
Case Reports
|